Clinical preventability of 30-day readmission after percutaneous coronary intervention

Jason H Wasfy, Jordan B Strom, Stephen W Waldo, Cashel O'Brien, Neil J Wimmer, Adrian H Zai, Jennifer Luttrell, John A Spertus, Kevin F Kennedy, Sharon-Lise T Normand, Laura Mauri, Robert W Yeh, Jason H Wasfy, Jordan B Strom, Stephen W Waldo, Cashel O'Brien, Neil J Wimmer, Adrian H Zai, Jennifer Luttrell, John A Spertus, Kevin F Kennedy, Sharon-Lise T Normand, Laura Mauri, Robert W Yeh

Abstract

Background: Early readmission after PCI is an important contributor to healthcare expenditures and a target for performance measurement. The extent to which 30-day readmissions after PCI are preventable is unknown yet essential to minimizing their occurrence.

Methods and results: PCI patients readmitted to hospital at which PCI was performed within 30 days of discharge at the Massachusetts General Hospital and Brigham and Women's Hospital were identified, and their medical records were independently reviewed by 2 physicians. Each reviewer used an ordinal scale (0, not; 1, possibly; 2, probably; and 3, definitely preventable) to rate clinical preventability, and a total sum score ≥2 was considered preventable. Characteristics of preventable and unpreventable readmissions were compared, and predictors of clinical preventability were assessed by using multivariate logistic regression. Of 9288 PCIs performed, 9081 (97.8%) patients survived to initial hospital discharge and 1007 (11.1%) were readmitted to the index hospital within 30 days. After excluding repeat readmissions, 893 readmissions were reviewed. Fair agreement between physician reviewers was observed (weighted κ statistic 0.44 [95% CI 0.39 to 0.49]). After aggregation of scores, 380 (42.6%) readmissions were deemed preventable and 513 (57.4%) were deemed not preventable. Common causes of preventable readmissions included staged PCI without new symptoms (14.7%), vascular/bleeding complications of PCI (10.0%), and congestive heart failure (9.7%).

Conclusions: Nearly half of 30-day readmissions after PCI may have been prevented by changes in clinical decision-making. Focusing on these readmissions may reduce readmission rates.

Keywords: Outcomes Research; Percutaneous Coronary Intervention; Performance Metrics; Quality Improvement; Readmission.

© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

Figures

Figure 1.
Figure 1.
Definitions of Preventability Categories.
Figure 2.
Figure 2.
Flow chart for excluded and included percutaneous coronary interventions (PCIs) in the creation of the database.
Figure 3.
Figure 3.
Preventability ratings of 2 reviewers
Figure 4.
Figure 4.
Factors associated with possible preventability for 30‐day readmission among readmitted patients. CABG indicates coronary artery bypass graft surgery; CVD, cerebrovascular disease; GFR, glomerular filtration rate; PCI, percutaneous coronary intervention; HMO, health maintenance organization; PAD, peripheral vascular disease.

References

    1. Promoting Greater Efficiency in Medicare. Medical Payment Advisory Commission (MedPAC), Washington, DC: 2007.
    1. Landen R. Hospital compare site adds PCI readmission [Internet]. Mod Healthc. 2013
    1. SCAI. SCAI Urges a No Endorsement Vote on NQF All‐cause PCI Readmission Measure [Internet] Available at: . Accessed February 24, 2014.
    1. Yost GW, Puher SL, Graham J, Scott TD, Skelding KA, Berger PB, Blankenship JC. Readmission in the 30 days after percutaneous coronary intervention. JACC Cardiovasc Interv. 2013; 6:237-244.
    1. Centers for Medicare and Medicaid Services. FY 2014 IPPS Final Rule Home Page Available at: . Accx2010essed September 17, 2014.
    1. Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM. All‐cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol. 2009; 54:903-907.
    1. Yeh RW, Rosenfield K, Zelevinsky K, Mauri L, Sakhuja R, Shivapour DM, Lovett A, Weiner BH, Jacobs AK, Normand S‐LT. Sources of hospital variation in short‐term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv. 2012; 5:227-236.
    1. Drozda J, Messer JV, Spertus J, Abramowitz B, Alexander K, Beam CT, Bonow RO, Burkiewicz JS, Crouch M, Goff DC, Hellman R, James T, King ML, Machado EA, Ortiz E, O'Toole M, Persell SD, Pines JM, Rybicki FJ, Sadwin LB, Sikkema JD, Smith PK, Torcson PJ, Wong JB. ACCF/AHA/AMA‐PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association—Physician Consortium for Performance Improvement. Circulation. 2011; 124:248-270.
    1. Frankl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmission. Am J Med. 1991; 90:667-674.
    1. Oddone EZ, Weinberger M, Horner M, Mengel C, Goldstein F, Ginier P, Smith D, Huey J, Farber NJ, Asch DA, Loo L, Mack E, Hurder AG, Henderson W, Feussner JR. Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med. 1996; 11:597-607.
    1. Experton B, Ozminkowski RJ, Pearlman DN, Li Z, Thompson S. How does managed care manage the frail elderly? The case of hospital readmissions in fee‐for‐service versus HMO systems. Am J Prev Med. 1999; 16:163-172.
    1. Dormann H, Neubert A, Criegee‐Rieck M, Egger T, Radespiel‐Tröger M, Azaz‐Livshits T, Levy M, Brune K, Hahn EG. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004; 255:653-663.
    1. Koekkoek D, Bayley KB, Brown A, Rustvold DL. Hospitalists assess the causes of early hospital readmissions. J Hosp Med. 2011; 6:383-388.
    1. Wasfy JH, Strom JB, O'Brien C, Zai AH, Luttrell J, Kennedy KF, Spertus JA, Zelevinsky K, Normand ST, Mauri L, Yeh RW. Causes of short‐term readmission after percutaneous coronary intervention. Circ Cardiovasc Interv. 2014; 7:97-103.
    1. Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand S‐LT, Yeh RW. A prediction model to identify patients at high risk for 30‐day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013; 6:429-435.
    1. Bates DW, O'Neil AC, Petersen LA, Lee TH, Brennan TA. Evaluation of screening criteria for adverse events in medical patients. Med Care. 1995; 33:452-462.
    1. Hain PD, Gay JC, Berutti TW, Whitney GM, Wang W, Saville BR. Preventability of early readmissions at a children's hospital. Pediatrics. 2013; 131:e171-e181.
    1. Minges KE, Curtis JP. Living in the readmission era. Circ Cardiovasc Interv. 2014; 7:9-10.
    1. Vachon CM, Aaland M, Zhu TH. Readmission of trauma patients in a nonacademic level II trauma center. J Trauma. 2011; 72:531-536.
    1. Potentially Preventable Readmissions Classification System: Methodology Overview. 3M Health Information Systems. 2008.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir